LAI
TNDM icon

Legal Advantage Investments’s Tandem Diabetes Care TNDM Stock Holding History

Legal Advantage Investments’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,000
Closed -$716K – 86
2021
Q3 		$716K Buy
6,000
+1,000
+20% +$110K 0.48% 52
2021
Q2 		$487K Hold
5,000
– – 0.33% 65
2021
Q1 		$441K Buy
+5,000
New +$465K 0.33% 63

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Legal Advantage Investments's TNDM Position: Q4 2021 in Review

Legal Advantage Investments sold out of Tandem Diabetes Care (TNDM) in Q4 2021, closing a stake of 6,000 shares — an estimated $716K sold.

Legal Advantage Investments first reported a position in TNDM in Q1 2021 and held it in 3 quarters. The position peaked at $716K in Q3 2021. 388 funds tracked by Wall St. Rank hold TNDM as of Q4 2021.

  • Legal Advantage Investments reported no remaining Tandem Diabetes Care position as of Q4 2021 after selling out during the quarter.
  • Legal Advantage Investments sold 6,000 Tandem Diabetes Care shares in Q4 2021, an estimated $716K.
  • Legal Advantage Investments first reported a position in Tandem Diabetes Care in Q1 2021 and held it in 3 quarters.
  • Legal Advantage Investments's Tandem Diabetes Care position peaked at $716K in Q3 2021.
  • 388 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2021.

Based on Legal Advantage Investments's 13F filing for Q4 2021, filed 8 Feb 2022.